Porphyria cutanea tarda precipitated by intravenous iron in a haemodialysis patient

Nephrology Dialysis Transplantation

Volumn 16, Issue 9, 2001, Pages 1936-1938

  McKane, William ^a   Green, Christina A ^a   Farrington, Ken ^a  

^a LISTER HOSPITAL   (United Kingdom)

Author keywords

Bullous dermatosis; Haemodialysis; Intravenous iron; Porphyria

Indexed keywords

ETHINYLESTRADIOL; FERRIC HYDROXIDE SUCROSE; IRON SACCHARATE; PREDNISONE; RECOMBINANT ERYTHROPOIETIN; UROPORPHYRINOGEN DECARBOXYLASE;

ADULT; ARTICLE; BULLOUS SKIN DISEASE; CASE REPORT; FEMALE; HEMODIALYSIS PATIENT; HUMAN; IMMUNOFLUORESCENCE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; PEMPHIGOID; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; SKIN BIOPSY;

EID: 0034851580     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.9.1936     Document Type: Article

References (9)

1. Bullous dermatosis of hemodialysis
2. Porphyrin studies in chronic renal failure patients on maintenance hemodialysis
3. Bullous dermatoses in end-stage renal failure: Porphyria or pseudoporphyria
4. Iron overload in porphyria cutanea tarda
5. Decreased uroporphyrinogen decarboxylase activity in patients with end-stage renal disease undergoing hemodialysis
6. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda
7. The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase
8. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure
9. Pseudoporphyria cutanea tarda in hemodialysis patients